Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × TP protocol × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 12 Thoracic 4 Head & Neck 4 Gynecologic 4 Breast 2 Other solid neoplasm 1 Dermatologic 1

Conditions

Neoplasm Metastasis 1 Melanoma 1

Interventions

Nivolumab 140 pembrolizumab 125 Ipilimumab 125 Cyclophosphamide 109 aldesleukin 59 Radiotherapy 59 Interleukin-2 58 fludarabine phosphate 55 Biopsy 45 Blood Specimen Collection 39 fludarabine 38 Temozolomide 37 Radiosurgery 37 Peripheral Blood Stem Cell Transplantation 37 trametinib 35 Vemurafenib 32 dabrafenib 30 sargramostim 29 Bevacizumab 28 Magnetic Resonance Spectroscopy 27 Aminolevulinic Acid 26 Surveys and Questionnaires 24 Photochemotherapy 24 Imiquimod 24 Specimen Handling 23 Mycophenolic Acid 23 Whole-Body Irradiation 22 Introns 22 Cyclosporine 22 Melphalan 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡